<?xml version="1.0" encoding="UTF-8"?>
<p>BDG is indicated as an adjunct to the diagnosis of invasive fungal disease. It is to be considered with reference to host, clinical, and other laboratory characteristics and findings. When an elevated BDG titer appears to be discordant with respect to these other observations, it is useful to evaluate potential sources of diagnostically false positive BDG presence. 
 <xref rid="jof-07-00014-t003" ref-type="table">Table 3</xref> provides a listing of a series of medical product and clinical condition-related questions which may help to clarify a previously unrecognized source of non-IFD-related BDG.
</p>
